Gertz MA - Search Results

1

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma.

Kaufman GP, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Lust JA, Russell S, Go RS, Hwa YL, Kyle RA, Rajkumar SV, Kumar SK. Kaufman GP, et al. Among authors: gertz ma. Leukemia. 2016 Mar;30(3):633-9. doi: 10.1038/leu.2015.287. Epub 2015 Oct 21. Leukemia. 2016. PMID: 26487275

2

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?

Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR. Witzig TE, et al. Among authors: gertz ma. Leuk Lymphoma. 1995 Nov;19(5-6):417-22. doi: 10.3109/10428199509112199. Leuk Lymphoma. 1995. PMID: 8590841

3

A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma.

Gertz MA, Garton JP, Greipp PR, Witzig TE, Kyle RA. Gertz MA, et al. Leukemia. 1995 Dec;9(12):2115-8. Leukemia. 1995. PMID: 8609725 Clinical Trial.

4

Primary systemic amyloidosis with delayed progression to multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA. Rajkumar SV, et al. Among authors: gertz ma. Cancer. 1998 Apr 15;82(8):1501-5. Cancer. 1998. PMID: 9554527

5

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.

Gertz MA, Lacy MQ, Inwards DJ, Chen MG, Pineda AA, Gastineau DA, Greipp PR, Lust JA, Tefferi A, Witzig TE, Kyle RA, Litzow MR. Gertz MA, et al. Bone Marrow Transplant. 1999 Feb;23(3):221-6. doi: 10.1038/sj.bmt.1701559. Bone Marrow Transplant. 1999. PMID: 10084252

6

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: gertz ma. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

7

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: gertz ma. J Clin Oncol. 1999 May;17(5):1551-7. doi: 10.1200/JCO.1999.17.5.1551. J Clin Oncol. 1999. PMID: 10334543

8

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Among authors: gertz ma. Bone Marrow Transplant. 1999 Jun;23(12):1261-6. doi: 10.1038/sj.bmt.1701787. Bone Marrow Transplant. 1999. PMID: 10414913 Clinical Trial.

9

Autologous stem cell transplantation for relapsed and primary refractory myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Among authors: gertz ma. Bone Marrow Transplant. 1999 Jun;23(12):1267-72. doi: 10.1038/sj.bmt.1701805. Bone Marrow Transplant. 1999. PMID: 10414914 Clinical Trial.

10

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis.

Gertz MA, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Kyle RA. Gertz MA, et al. Med Oncol. 1999 Jul;16(2):104-9. doi: 10.1007/BF02785843. Med Oncol. 1999. PMID: 10456658 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

952 results

Search Page

Filters